Evidence map›Paper›PMID 30455477›Full record

ArticleNature protocols2018

Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins.

Jonathan Elegheert, Ester Behiels, Benjamin Bishop, Suzanne Scott, Rachel E Woolley, Samuel C Griffiths, Eamon F X Byrne, Veronica T Chang, David I Stuart, E Yvonne Jones and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 215 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Smoking promotes colorectal cancer via the CKAP2L/AREG axis.International journal of oncology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Discovery of Obacunone as a TGR5 Agonist fromInternational journal of molecular sciences · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Methods for Investigating Siglec-Ganglioside Interactions.Methods in molecular biology (Clifton, N.J.) · 2026
    Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jonathan ElegheertDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. jonathan.elegheert@u-bordeaux.fr.ORCID http://orcid.org/0000-0002-4196-4813
Ester BehielsDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Benjamin BishopDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Suzanne ScottDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Rachel E WoolleyDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Samuel C GriffithsDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Eamon F X ByrneDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Veronica T ChangMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
David I StuartDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
E Yvonne JonesDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Christian SieboldDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. christian@strubi.ox.ac.uk.
A Radu AricescuDivision of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK. radu@mrc-lmb.cam.ac.uk.
Centre for Human Genetics · GBCentre National de la Recherche Scientifique · FRMRC Laboratory of Molecular Biology · GB

Funding

Cancer Research UK 14414Cancer Research UK 17721Cancer Research UK 26752Medical Research Council G1100525Medical Research Council MC_EX_MR/L009609/2Medical Research Council MC_UP_1201/15Medical Research Council MR/L009609/1Medical Research Council MR/L017776/1Medical Research Council MR/M000141/1Medical Research Council MR/N00065X/1Wellcome Trust
6 · The paper itself

Abstract

Structural, biochemical and biophysical studies of eukaryotic soluble and membrane proteins require their production in milligram quantities. Although large-scale protein expression strategies based on transient or stable transfection of mammalian cells are well established, they are associated with high consumable costs, limited transfection efficiency or long and tedious selection of clonal cell lines. Lentiviral transduction is an efficient method for the delivery of transgenes to mammalian cells and unifies the ease of use and speed of transient transfection with the robust expression of stable cell lines. In this protocol, we describe the design and step-by-step application of a lentiviral plasmid suite, termed pHR-CMV-TetO

Indexed as

BiotechnologyGene ExpressionHEK293 CellsHumansLentivirusMembrane ProteinsPlasmidsTime FactorsTransduction, GeneticMembrane Proteins

Identifiers

PMID30455477
PMCPMC6364805
OpenAlexW2901641202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.